Global Small Molecule API Market By Manufacturers, Type And Application, Regions, Forecast to 2022

Small Molecule API Market 2017

In this report, the global Small Molecule API market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Small Molecule API for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India    

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/1909358-global-small-molecule-api-sales-market-report-2017       

                

Global Small Molecule API market competition by top manufacturers/players, with Small Molecule API sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline PLC, GILEAD Science Inc.
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co, Inc.
BASF SE
Catalent Inc.
Teva Pharmaceuticals
F. Hoffmann-La Roche Ltd
Cambrex Corporation
GILEAD Science Inc. 

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Standard API
High Potency API 

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Small Molecule API for each application, including
Cardiovascular
Respiratory
Infectious
Metabolic
Oncology
Immunology
Neurology
Others

Complete Report Details @ https://www.wiseguyreports.com/reports/1909358-global-small-molecule-api-sales-market-report-2017                                                                                                                                                                                                                                 

Table of Contents

Global Small Molecule API Sales Market Report 2017
1 Small Molecule API Market Overview 1.1 Product Overview and Scope of Small Molecule API
1.2 Classification of Small Molecule API by Product Category
1.2.1 Global Small Molecule API Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Small Molecule API Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Standard API
1.2.4 High Potency API
1.3 Global Small Molecule API Market by Application/End Users
1.3.1 Global Small Molecule API Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Cardiovascular
1.3.3 Respiratory
1.3.4 Infectious
1.3.5 Metabolic
1.3.6 Oncology
1.3.7 Immunology
1.3.8 Neurology
1.3.9 Others
1.4 Global Small Molecule API Market by Region
1.4.1 Global Small Molecule API Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Small Molecule API Status and Prospect (2012-2022)
1.4.3 China Small Molecule API Status and Prospect (2012-2022)
1.4.4 Europe Small Molecule API Status and Prospect (2012-2022)
1.4.5 Japan Small Molecule API Status and Prospect (2012-2022)
1.4.6 Southeast Asia Small Molecule API Status and Prospect (2012-2022)
1.4.7 India Small Molecule API Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Small Molecule API (2012-2022)
1.5.1 Global Small Molecule API Sales and Growth Rate (2012-2022)
1.5.2 Global Small Molecule API Revenue and Growth Rate (2012-2022)

…..

9 Global Small Molecule API Players/Suppliers Profiles and Sales Data
9.1 Johnson Matthey 9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Small Molecule API Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Johnson Matthey Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Siegfried Holding AG 9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Small Molecule API Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Siegfried Holding AG Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Pfizer 9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Small Molecule API Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Pfizer Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Sanofi S.A. 9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Small Molecule API Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Sanofi S.A. Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Novartis AG 9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Small Molecule API Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Novartis AG Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Bristol-Myers Squibb 9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Small Molecule API Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Bristol-Myers Squibb Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Boehringer Ingelheim GmbH 9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Small Molecule API Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Boehringer Ingelheim GmbH Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 GlaxoSmithKline PLC, GILEAD Science Inc. 9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Small Molecule API Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 GlaxoSmithKline PLC, GILEAD Science Inc. Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Albany Molecular Research Inc. 9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Small Molecule API Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Albany Molecular Research Inc. Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Bachem Holding AG 9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Small Molecule API Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Bachem Holding AG Small Molecule API Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 PCAS
9.12 Patheon N.V.
9.13 AstraZeneca
9.14 Johnson & Johnson
9.15 Merck & Co, Inc.
9.16 BASF SE
9.17 Catalent Inc.
9.18 Teva Pharmaceuticals
9.19 F. Hoffmann-La Roche Ltd
9.20 Cambrex Corporation
9.21 GILEAD Science Inc.

 Continued…….

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check :

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check :

https://www.wiseguyreports.com/seminars

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Small Molecule API Market 2017: Global Industry Analysis and Opportunity Assessment, Forecast to 2027

Small Molecule API Market 2017

Introduction The global small molecule API market was valued at $ 132,877.3 million in 2016 and expected to reach $ 279,687.1 million by 2027 at a CAGR of 7 % during the forecast period.

The major factors responsible for the growth of global Small molecule API market are growing demand for newly developed small molecules drugs, growing trend of outsourcing and growing pharmaceutical industry in developing nations. The growth barriers are and austerity measures in Europe among others.

The market is majorly categorized on the basis of types which is further segmented into synthetic/chemical API and biological API. On the basis of application the market is segmented into cardiovascular, oncology, diabetes and immunological disorders. On the basis of manufacturing methods the market is segmented into in-house manufacturing and contract manufacturing and geographic regions. 

Globally, North America holds the largest market share of global small molecule API market, registering 38.84 % in 2016.  

The scope of global small molecule API market study includes the market value, market size and a detailed analysis of vendor products and strategies. 

Key Players,The leading players of the global small molecule API market are Albemarle Corporation, Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Dr. Reddy’s laboratories ltd., Glaxosmithkline Plc, Lonza , Merck Sharp & Dohme Corp., Mylan N.V., Pfizer Inc., Novartis AG, Siegfried AG , Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd. and others.

Study Objectives of Small molecule API Market Development and Demand Forecast to 2027 Market
Ø    To provide insights about factors, influencing and affecting the market growth
Ø    To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
Ø    To provide historically and forecast revenue of the market segments based on type, and sub-segment for global Small molecule API market 
Ø    To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Ø    To provide economic factors that influence the global Small molecule API market      

Request For Sample Report @ https://www.wiseguyreports.com/sample-request/1292097-global-small-molecule-api-market-estimation-forecast-2013-2027  

  

Target Audience
•    Small molecule API companies
•    Raw Material Suppliers
•    Key executive (CEO and COO) and strategy growth manager   

        

Key Findings• On the basis of types, synthetic/chemical API accounted for the largest market share of 81.31 % in 2016.
• US accounted for the largest market share of 59.75 % in 2016, with a market value of USD 30,848.3 million and is projected to grow at a CAGR of 6.6 % during the forecast period.

The reports also cover country level analysis:• North America
• US
• Canada
• Europe
• Western Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Asia-Pacific
• China
• Japan
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa

Complete Report Details @ https://www.wiseguyreports.com/reports/1292097-global-small-molecule-api-market-estimation-forecast-2013-2027                                                                                                                                                                                                               

Table of Contents    

     

1 INTRODUCTION 121.1 DEFINITION 12
1.2 SCOPE OF STUDY 12
1.2.1 RESEARCH OBJECTIVE 12
1.2.2 ASSUMPTIONS & LIMITATIONS 13
1.2.2.1 ASSUMPTIONS 13
1.2.2.2 LIMITATIONS 13
1.3 MARKET STRUCTURE: 13

…..

10 COMPANY PROFILE 80
10.1 ALBEMARLE CORPORATION 8010.1.1 OVERVIEW 80
10.1.2 PRODUCT OVERVIEW 80
10.1.3 FINANCIALS 81
10.1.4 KEY DEVELOPMENTS 81
10.2 ALLERGAN PLC 8210.2.1 OVERVIEW 82
10.2.2 PRODUCT OVERVIEW 82
10.2.3 FINANCIALS 83
10.2.4 KEY DEVELOPMENTS 83
10.3 AUROBINDO PHARMA 8410.3.1 OVERVIEW 84
10.3.2 PRODUCT OVERVIEW 84
10.3.3 FINANCIALS 85
10.3.4 STRATEGY 85
10.3.5 KEY DEVELOPMENT 85
10.4 CAMBREX CORPORATION 8610.4.1 OVERVIEW 86
10.4.2 PRODUCT OVERVIEW 86
10.4.3 FINANCIALS 87
10.4.4 KEY DEVELOPMENTS 87
10.5 DR. REDDY’S LABORATORIES LTD. 8810.5.1 OVERVIEW 88
10.5.2 PRODUCT OVERVIEW 88
10.5.3 FINANCIALS 89
10.5.4 KEY DEVELOPMENTS 89
10.6 GLAXOSMITHKLINE PLC 9010.6.1 OVERVIEW 90
10.6.2 PRODUCT OVERVIEW 90
10.6.3 FINANCIALS 91
10.6.4 STRATEGY 91
10.6.5 KEY DEVELOPMENTS 92
10.7 LONZA 9210.7.1 OVERVIEW 92
10.7.2 PRODUCT OVERVIEW 92
10.7.3 FINANCIALS 93
10.7.4 STRATEGY 93
10.7.5 KEY DEVELOPMENTS 94
10.8 MERCK SHARP & DOHME CORP. 9410.8.1 OVERVIEW 94
10.8.2 PRODUCT OVERVIEW 95
10.8.3 FINANCIAL 95
10.8.4 KEY DEVELOPMENTS 96
10.9 MYLAN N.V. 9610.9.1 OVERVIEW 96
10.9.2 PRODUCT OVERVIEW 97
10.9.3 FINANCIALS 97
10.9.4 KEY DEVELOPMENTS 98
10.10 NOVARTIS AG 9810.10.1 OVERVIEW 98
10.10.2 PRODUCT OVERVIEW 99
10.10.3 FINANCIALS 99
10.10.4 STRATEGY 99
10.10.5 DEVELOPMENTS 100
10.11 PFIZER INC. 10010.11.1 OVERVIEW 100
10.11.2 PRODUCT OVERVIEW 101
10.11.3 FINANCIALS 101
10.11.4 KEY DEVELOPMENTS 102
10.12 SIEGFRIED AG 10210.12.1 OVERVIEW 102
10.12.2 PRODUCT OVERVIEW 102
10.12.3 FINANCIALS 103
10.12.4 KEY DEVELOPMENTS 103
10.13 SUN PHARMACEUTICAL INDUSTRIES LTD. 10410.13.1 OVERVIEW 104
10.13.2 PRODUCT OVERVIEW 104
10.13.3 FINANCIALS 105
10.13.4 KEY DEVELOPMENTS 105
10.14 TEVA PHARMACEUTICAL INDUSTRIES LTD 10610.14.1 OVERVIEW 106
10.14.2 PRODUCT OVERVIEW 106
10.14.3 FINANCIALS 107
10.14.4 STRATEGY 107
10.14.5 KEY DEVELOPMENTS 108

 Continued…….

For accessing accurate and deep understanding and to gain latest insights and key developments in the area of your interest, we also have a list of conferences in which you will be interested in, for more information, cordially check :

https://www.wiseguyreports.com/conferences

For updating knowledge or for thoroughly understanding various terminologies, we also have vast list of seminars for your reference, for more information cordially check :

https://www.wiseguyreports.com/seminars

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)